Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and/or under 1500 g: A systematic literature review-Reference-Cited by-同舟云学术

Penta- and hexavalent vaccination of extremely and very-to-moderate preterm infants born at less than 34 weeks and/or under 1500 g: A systematic literature review

Published:2023-01-02 Issue:1 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Knuf Markus¹²,Charkaluk Marie-Laure³⁴⁵^ORCID,The Nguyen Phung Nguyen⁶^ORCID,Salamanca de la Cueva Ignacio⁷^ORCID,Köbrunner Petra⁸,Mason Lauren⁸,Duchenne Maurine⁹,Berlaimont Valérie⁹

Affiliation:

1. Department for Pediatric and Adolescent Medicine, Children’s Hospital Worms, Worms, Germany

2. Pediatric Infectious Diseases, University of Medicine, Mainz, Germany

3. Neonatology Department, Saint Vincent de Paul Hospital, GHICL, Lille, France

4. Faculty of Medicine, Maieutics and Health Sciences, Université Catholique de Lille, Lille, France

5. CRESS, Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, INSERM, INRAE, Université Paris Cité, Paris, France

6. Pediatric Department, University of Medicine and Pharmacy, Ho Chi Minh City, Vietnam

7. Unidad de Investigación, Grupo Instituto Hispalense de Pediatría, Sevilla, Spain

8. Pallas Health Research and Consultancy, Rotterdam, The Netherlands

9. GSK vaccine, GlaxoSmithKline Pharmaceuticals SA/NV, Wavre, Belgium

Funder

GlaxoSmithKline Biologicals SA. GlaxoSmithKline

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2191575

Reference63 articles.

1. Combination vaccines

2. Manufacturing DTaP-based combination vaccines: industrial challenges around essential public health tools

3. New perspectives for hexavalent vaccines

4. World Health Organization. DT-based combined vaccines. World Health Organization. [Accessed 2022 Jul 22]. https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccine-standardization/dt-based-combined-vaccines.

5. Hexavalent vaccines: characteristics of available products and practical considerations from a panel of Italian experts;Orsi A;J Prev Med Hyg,2018